Smilow Cancer Hospital at Yale-New Haven
The new Smilow Cancer Hospital at Yale-New Haven consolidates all of the medical center's cancer services, both inpatient and outpatient, into a single world-class cancer hospital. Smilow Cancer Hospital is affiliated with
Yale Cancer Center - southern New England's only comprehensive cancer center designated by the National Cancer Institute, and one of only 40 in the United States.
The new cancer hospital provides the very best cancer care available, brings together some of the nation’s best minds to develop new methods to prevent, diagnose and treat cancer, and attracts additional high-level talent to Yale-New Haven Hospital.
Some of Smilow’s special features include a roof-top healing garden on the seventh floor – an outdoor garden, complete with trees, shrubs, plants, a small stream, benches and lovely views of New Haven. Smilow has a magnificent two-story glass lobby with a terrazzo floor, a granite waterwall, terracotta walls and maple woodwork. A special boutique will help patients look and feel better, despite their illness.
The building is named after Yale alumnus Joel E. Smilow (Yale College, ’54), former chair, chief executive officer and president of Playtex Products, Inc. He and his wife, Joan, gave a major gift to support the cancer hospital.
Premier clinical care at Smilow Cancer Hospital
Yale-New Haven Hospital treats more cancer patients than any other hospital in Connecticut. A team from one of Smilow’s 12 cancer programs meets to discuss each patient’s diagnosis and therapy options, resulting in the development of a unique, comprehensive treatment plan for each patient that can include surgery, chemotherapy, radiation, a combination of treatments or conservative monitoring. YNHH offers the latest in screening and diagnosis, genetic counseling, treatment, psychosocial support, pain management, rehabilitation and long-term, follow-up care. In addition, Yale- New Haven patients often have the opportunity to take advantage of clinical trials which are not available at most hospitals.
The quality of care and outcomes for patients treated at Yale Cancer Center are among the
best in the nation.
Looking to the future
Smilow Cancer Hospital at Yale-New Haven will continue to build on the rich scientific tradition of Yale Cancer Center. Yale Cancer Center is expanding clinical trials and developing a clinical program that will provide molecular profiling services to enable targeted therapies. In addition, Yale is creating a new cancer biology institute at its 136-acre West Campus in West Haven, CT, which will focus on research in the fields of cell signaling, cancer immunology and drug development, and target acquisition.
